BridgeBio Pharma, Inc. Shares Outstanding (Cover Page)
BridgeBio Pharma, Inc. (BBIO) had Shares Outstanding (Cover Page) of 195.49 million shares as of 2026-08-03, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-03: Entity Common Stock, Shares Outstanding 195.49M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 195.86M shares.
- 2026-02-12: Entity Common Stock, Shares Outstanding 193.86M shares.
- 2025-10-21: Entity Common Stock, Shares Outstanding 192.71M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 195.49M shares 10-Q · filed 2026-08-10 |
| 2026-04-30 | 195.86M shares 10-Q · filed 2026-05-07 |
| 2026-02-12 | 193.86M shares 10-K · filed 2026-02-24 |
| 2025-10-21 | 192.71M shares 10-Q · filed 2025-10-29 |
| 2025-07-29 | 191.17M shares 10-Q · filed 2025-08-05 |
| 2025-04-22 | 189.88M shares 10-Q · filed 2025-04-29 |
| 2025-02-13 | 190.19M shares 10-K · filed 2025-02-20 |
| 2024-11-05 | 188.99M shares 10-Q · filed 2024-11-12 |
| 2024-07-25 | 188.03M shares 10-Q · filed 2024-08-01 |
| 2024-04-25 | 187.13M shares 10-Q · filed 2024-05-02 |
| 2024-02-15 | 175.83M shares 10-K · filed 2024-02-22 |
| 2023-10-26 | 173.97M shares 10-Q · filed 2023-11-02 |
| 2023-07-31 | 162.47M shares 10-Q · filed 2023-08-03 |
| 2023-04-24 | 160.50M shares 10-Q · filed 2023-05-04 |
| 2023-02-16 | 151.37M shares 10-K · filed 2023-02-23 |
| 2022-10-28 | 149.48M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 148.25M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 147.69M shares 10-Q · filed 2022-05-05 |
| 2022-02-18 | 147.61M shares 10-K · filed 2022-02-25 |
| 2021-10-29 | 147.17M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 149.77M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 149.28M shares 10-Q · filed 2021-05-06 |
| 2021-02-19 | 148.96M shares 10-K · filed 2021-02-25 |
| 2020-10-30 | 122.57M shares 10-Q · filed 2020-11-05 |
| 2020-08-05 | 122.36M shares 10-Q · filed 2020-08-11 |
| 2020-05-08 | 121.37M shares 10-Q · filed 2020-05-14 |
| 2020-02-24 | 123.77M shares 10-K · filed 2020-03-03 |
| 2019-11-05 | 123.57M shares 10-Q · filed 2019-11-08 |
| 2019-08-09 | 116.76M shares 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |